{"DataElement":{"publicId":"4749192","version":"1","preferredName":"Residual Cancer Tumor Burden Post Neoadjuvant Therapy Category","preferredDefinition":"Distinct grouping or class based on result of the Residual Cancer Burden after neoadjuvant chemotherapy.","longName":"4749188v1.0:4749189v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"4749188","version":"1","preferredName":"Residual Cancer Tumor Burden Post Neoadjuvant Therapy","preferredDefinition":"Reference to the residual tumor or cancer burden left after intervention._Happening at a time subsequent to a reference time; later in time or order._Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy.","longName":"RESID_CA_BRDN","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"4749186","version":"1","preferredName":"Residual Post Neoadjuvant Therapy Malignant Neoplasm","preferredDefinition":"Remaining or left behind.:Happening at a time subsequent to a reference time; later in time or order.:Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. :A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","longName":"C37895:C38008:C15665:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-35A9-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ONEDATA","dateModified":"2015-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2551887","version":"1","preferredName":"Tumor Burden","preferredDefinition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body. Also called tumor load.","longName":"C28384","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Burden","conceptCode":"C28384","definition":"Refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2409799C-18EB-3CC1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"ONEDATA","dateModified":"2006-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-35B7-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4749189","version":"1","preferredName":"Residual Cancer Burden Category","preferredDefinition":"information related to Residual Cancer Burden (RCB) results.","longName":"RES_CA_BRDN_CAT","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"One to three cm","valueDescription":"One to three cm","ValueMeaning":{"publicId":"4749191","version":"1","preferredName":"One to three cm","longName":"4749191","preferredDefinition":"One to three cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-3649-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11BA3CF7-3662-1FF9-E050-BB89AD43480D","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ONEDATA","dateModified":"2015-03-20","deletedIndicator":"No"},{"value":"Greater than 3 cm","valueDescription":"Greater than 3 cm","ValueMeaning":{"publicId":"4749190","version":"1","preferredName":"Greater than 3 cm","longName":"4749190","preferredDefinition":"Greater than 3 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-3626-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11BA3CF7-363F-1FF9-E050-BB89AD43480D","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ONEDATA","dateModified":"2015-03-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2611633","version":"1","preferredName":"Residual Cancer Burden Category","preferredDefinition":"Remaining or left behind.:A measure of the incidence of cancer within the population and an estimate of the financial, emotional, or social impact it creates. The burden of disease is not borne equally by all population groups in the United State.:Category; used informally to mean a class of things.","longName":"C37895:C16064:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cancer Burden","conceptCode":"C16064","definition":"A measure of the incidence of cancer within the population and an estimate of the financial, emotional, or social impact it creates. The burden of disease is not borne equally by all population groups in the United State.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B7B7BC4-47AF-6CA3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-12","modifiedBy":"ONEDATA","dateModified":"2007-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-3612-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeDescription":"New version of VD to change value meanings, and add 1 new permissible value for I-SPY project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Residual cancer burden after","type":"Preferred Question Text","description":"Residual cancer burden after neoadjuvant chemotherapy","url":null,"context":"ECOG-ACRIN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11BA3CF7-36DB-1FF9-E050-BB89AD43480D","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-03-20","modifiedBy":"ROUILLAS","dateModified":"2015-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}